Neuropsychopharmacology
- Efficacy and safety of JNJ-42165279, a fatty acid amide hydrolase inhibitor, in adolescents and adults with autism spectrum disorder: a randomized, phase 2, placebo-controlled study1 year ago
- PET clinical study of novel antipsychotic LB-102 demonstrates unexpectedly prolonged dopamine receptor target engagement1 year ago
- Small-molecule natural product sophoricoside reduces peripheral neuropathic pain via directly blocking of NaV1.6 in dorsal root ganglion nociceptive neurons1 year ago
- Sex-specific and developmental effects of early life adversity on stress reactivity are rescued by postnatal knockdown of 5-HT1A autoreceptors1 year ago
- Autism spectrum disorder-like behaviors induced by hyper-glutamatergic NMDA receptor signaling through hypo-serotonergic 5-HT1A receptor signaling in the prefrontal cortex in mice exposed to prenatal valproic acid1 year ago
- Neuroimaging in psychiatry: toward mechanistic insights and clinical utility1 year ago
- Effects of ketamine on GABAergic and glutamatergic activity in the mPFC: biphasic recruitment of GABA function in antidepressant-like responses1 year ago
Journal of Psychopharmacology
- Abuse potential assessment of the dual orexin receptor antagonist daridorexant in rats2 years ago
- Development of the Protective Strategies for Psychedelics Scale: A novel inventory to assess safety strategies in the context of psychedelics2 years ago
- Treating posttraumatic stress disorder and alcohol use disorder comorbidity: Current pharmacological therapies and the future of MDMA-integrated psychotherapy2 years ago
- Value-based decision-making predicts alcohol use and related problems in young men2 years ago
- The 5-HT7 receptor system as a treatment target for mood and anxiety disorders: A systematic review2 years ago
- Drug–drug interactions involving classic psychedelics: A systematic review2 years ago
- Failure of the dual orexin receptor antagonist suvorexant to engender drug discrimination in rats2 years ago
European Neuropsychopharmacology
- Duration of the psychosis prodrome and its relationship to duration of untreated psychosis across all 12 DSM-IV psychotic diagnoses: Evidence for a trans-diagnostic process associated with resilience2 years ago
- Clinical features in co-occuring obsessive-compulsive disorder and bipolar disorder: A systematic review and meta-analysis2 years ago
- Teratogenicity of valproate: Further reasons for action2 years ago
- The complex scenario behind the term antipsychotic drug2 years ago
- Can antipsychotics prevent transition to psychosis in high-risk population?2 years ago
- From gut to brain: A network model of intestinal permeability, inflammation, and psychotic symptoms in schizophrenia.2 years ago
- Cognitive impairment after recovery from COVID-19: Frequency, profile, and relationships with clinical and laboratory indices2 years ago